Literature DB >> 30819690

Early hydroxychloroquine retinopathy: optical coherence tomography abnormalities preceding Humphrey visual field defects.

Sean T Garrity1, Joo Yeon Jung2, Olivia Zambrowski3, Francesco Pichi4,5, Daniel Su6, Malvika Arya1, Nadia K Waheed1, Jay S Duker1, Yaïr Chetrit7, Elisabetta Miserocchi8, Chiara Giuffrè8, Talia R Kaden9,10,11,12, Giuseppe Querques13, Eric H Souied3,14, K Bailey Freund9,10,11, David Sarraf15,16.   

Abstract

BACKGROUND/AIMS: Hydroxychloroquine (HCQ) retinopathy may result in severe and irreversible vision loss, emphasising the importance of screening and early detection. The purpose of this study is to report the novel finding of early optical coherence tomography (OCT) abnormalities due to HCQ toxicity that may develop in the setting of normal Humphrey visual field (HVF) testing.
METHODS: Data from patients with chronic HCQ exposure was obtained from seven tertiary care retina centres. Ten patients with HCQ-associated OCT abnormalities and normal HVF testing were identified. Detailed analysis of the OCT findings and ancillary tests including colour fundus photography, fundus autofluorescence, multifocal electroretinography and microperimetry was performed in these patients.
RESULTS: Seventeen eyes from 10 patients illustrated abnormalities with OCT and normal HVF testing. These OCT alterations included (1) attenuation of the parafoveal ellipsoid zone and (2) loss of a clear continuous interdigitation zone. Several eyes progressed to advanced parafoveal outer retinal disruption and/or paracentral visual field defects.
CONCLUSION: Patients with high risk HCQ exposure and normal HVF testing may develop subtle but characteristic OCT abnormalities. This novel finding indicates that, in some cases of early HCQ toxicity, structural alterations may precede functional impairment. It is therefore important to employ a screening approach that includes OCT to assess for these early findings. Ancillary testing should be considered in cases with suspicious OCT changes and normal HVFs. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  diagnostic tests/Investigation; drugs; imaging; macula; retina

Mesh:

Substances:

Year:  2019        PMID: 30819690     DOI: 10.1136/bjophthalmol-2018-313350

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  7 in total

1.  Visual Field Sensitivity Prediction Using Optical Coherence Tomography Analysis in Hydroxychloroquine Toxicity.

Authors:  Gopal Jayakar; Tharindu De Silva; Catherine A Cukras
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

2.  Visual field examinations using different strategies in Asian patients taking hydroxychloroquine.

Authors:  Ko Eun Kim; So Jung Ryu; Young Hwan Kim; Yuchan Seo; Seong Joon Ahn
Journal:  Sci Rep       Date:  2022-08-30       Impact factor: 4.996

3.  Quantitative autofluorescence findings in patients undergoing hydroxychloroquine treatment.

Authors:  Salvatore Parrulli; Mariano Cozzi; Matteo Airaldi; Francesco Romano; Francesco Viola; Piercarlo Sarzi-Puttini; Giovanni Staurenghi; Alessandro Invernizzi
Journal:  Clin Exp Ophthalmol       Date:  2022-05-14       Impact factor: 4.383

4.  Spectral-Domain Optical Coherence Tomography Is More Sensitive for Hydroxychloroquine-Related Structural Abnormalities Than Short-Wavelength and Near-Infrared Autofluorescence.

Authors:  Ruben Jauregui; Rait Parmann; Yan Nuzbrokh; Stephen H Tsang; Janet R Sparrow
Journal:  Transl Vis Sci Technol       Date:  2020-08-05       Impact factor: 3.283

Review 5.  Wide field retinal imaging and the detection of drug associated retinal toxicity.

Authors:  Giulia Corradetti; Sara Violanti; Adrian Au; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2019-12-12

6.  Quantitative Fundus Autofluorescence in HCQ Retinopathy.

Authors:  Vivienne C Greenstein; Jose Ronaldo Lima de Carvalho; Rait Parmann; Luz Amaro-Quireza; Winston Lee; Donald C Hood; Stephen H Tsang; Janet R Sparrow
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-09-01       Impact factor: 4.799

7.  Quantitative Fundus Autofluorescence in Systemic Chloroquine/Hydroxychloroquine Therapy.

Authors:  Clara Reichel; Andreas Berlin; Victoria Radun; Ioana-Sandra Tarau; Jost Hillenkamp; Nikolai Kleefeldt; Kenneth R Sloan; Thomas Ach
Journal:  Transl Vis Sci Technol       Date:  2020-08-28       Impact factor: 3.283

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.